{"id":"https://openalex.org/W2176527369","doi":null,"title":"Silibinin administration improves hepatic failure due to extensive liver infiltration in a breast cancer patient.","display_name":"Silibinin administration improves hepatic failure due to extensive liver infiltration in a breast cancer patient.","publication_year":2014,"publication_date":"2014-08-01","ids":{"openalex":"https://openalex.org/W2176527369","mag":"2176527369","pmid":"https://pubmed.ncbi.nlm.nih.gov/25075066"},"language":"en","primary_location":{"id":"pmid:25075066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25075066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Case Reports"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5025874415","display_name":"Joaquim Bosch\u2010Barrera","orcid":"https://orcid.org/0000-0002-0893-7821","observed_orcids":["https://orcid.org/0000-0002-0893-7821"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210113168","display_name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona","ror":"https://ror.org/020yb3m85","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113168","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Joaquim Bosch-Barrera","raw_affiliation_strings":["Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain jbosch@iconcologia.net","1Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain jbosch@iconcologia.net","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210113168"]},{"raw_affiliation_string":"1Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain","institution_ids":["https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111716658","display_name":"Bruna Corominas-Faja","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210113168","display_name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona","ror":"https://ror.org/020yb3m85","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113168","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bruna Corominas-Faja","raw_affiliation_strings":["Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210113168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060700554","display_name":"Elisabet Cuy\u00e0s","orcid":"https://orcid.org/0000-0001-5353-440X","observed_orcids":["https://orcid.org/0000-0001-5353-440X"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210113168","display_name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona","ror":"https://ror.org/020yb3m85","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113168","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elisabet Cuy\u00e0s","raw_affiliation_strings":["Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210113168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040427139","display_name":"Bego\u00f1a Mart\u00edn-Castillo","orcid":"https://orcid.org/0000-0001-8344-8174","observed_orcids":["https://orcid.org/0000-0001-8344-8174"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210113168","display_name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona","ror":"https://ror.org/020yb3m85","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113168","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Bego\u00f1a Martin-Castillo","raw_affiliation_strings":["Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Unit of Clinical Research, Catalan Institute of Oncology, Girona, Catalonia, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210113168"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059910653","display_name":"Joan Brunet","orcid":"https://orcid.org/0000-0003-1945-3512","observed_orcids":["https://orcid.org/0000-0003-1945-3512"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210113168","display_name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona","ror":"https://ror.org/020yb3m85","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113168","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Joan Brunet","raw_affiliation_strings":["Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210113168"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077187730","display_name":"Javier Abel Men\u00e9ndez","orcid":"https://orcid.org/0000-0001-8733-4561","observed_orcids":["https://orcid.org/0000-0001-8733-4561"]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210113168","display_name":"Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona","ror":"https://ror.org/020yb3m85","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113168","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier A Menendez","raw_affiliation_strings":["Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Girona Biomedical Research Institute (IDIBGi), Girona, Catalonia, Spain Metabolism & Cancer Group, Translational Research Laboratory, Catalan Institute of Oncology, Girona, Catalonia, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210113168"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3402,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.80192404,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"34","issue":"8","first_page":"4323","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12689","display_name":"Silymarin and Mushroom Poisoning","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12689","display_name":"Silymarin and Mushroom Poisoning","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12750","display_name":"Nigella sativa pharmacological applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/silibinin","display_name":"silibinin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/silymarin","display_name":"silymarin","score":0.8270000219345093},{"id":"https://openalex.org/keywords/liver-failure","display_name":"liver failure","score":0.7289999723434448},{"id":"https://openalex.org/keywords/liver-infiltration","display_name":"liver infiltration","score":0.765999972820282},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9620000123977661},{"id":"https://openalex.org/keywords/hepatoprotective-effect","display_name":"hepatoprotection","score":0.8270000219345093},{"id":"https://openalex.org/keywords/nutraceuticals","display_name":"nutraceuticals","score":0.8730000257492065},{"id":"https://openalex.org/keywords/expanded-access","display_name":"compassionate use","score":0.7549999952316284},{"id":"https://openalex.org/keywords/palliative-chemotherapy","display_name":"palliative chemotherapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/chemotherapy-induced-liver-injury","display_name":"chemotherapy-induced liver injury","score":0.5609999895095825}],"concepts":[{"id":"https://openalex.org/C2777130413","wikidata":"https://www.wikidata.org/wiki/Q425702","display_name":"Silibinin","level":2,"score":0.9148679971694946},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8609411716461182},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5777173042297363},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.5367966890335083},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5342843532562256},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.45862290263175964},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.44674810767173767},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4461362659931183},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.4357566237449646},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.42623600363731384},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41929519176483154},{"id":"https://openalex.org/C2776231280","wikidata":"https://www.wikidata.org/wiki/Q623031","display_name":"Liver cancer","level":3,"score":0.41315987706184387},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3419094681739807},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3405595123767853},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24425387382507324},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.1920715570449829},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.10578826069831848}],"mesh":[{"descriptor_ui":"D000077385","descriptor_name":"Silybin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D012838","descriptor_name":"Silymarin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014810","descriptor_name":"Vitamin E","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017093","descriptor_name":"Liver Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:25075066","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25075066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anticancer research","raw_type":"Case Reports"},{"id":"mag:2176527369","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25075066","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Case Report","id":"https://openalex.org/study-designs/case-report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1978708377","https://openalex.org/W1979191248","https://openalex.org/W1982327750","https://openalex.org/W1993660328","https://openalex.org/W2023113664","https://openalex.org/W2036805643","https://openalex.org/W2060273830","https://openalex.org/W2065594264","https://openalex.org/W2069356522","https://openalex.org/W2091479905","https://openalex.org/W2107686567","https://openalex.org/W2131080175","https://openalex.org/W2139274035","https://openalex.org/W2154553542","https://openalex.org/W2158158246","https://openalex.org/W2168571064","https://openalex.org/W2168613688"],"related_works":["https://openalex.org/W3149548298","https://openalex.org/W4389367019","https://openalex.org/W4404830557","https://openalex.org/W1966166986","https://openalex.org/W2047681569","https://openalex.org/W3148166908","https://openalex.org/W2123761405","https://openalex.org/W200750902","https://openalex.org/W1977475850","https://openalex.org/W2135799785"],"abstract_inverted_index":{"BACKGROUND:":[0],"Silibinin":[1],"exerts":[2],"hepatoprotective,":[3],"anti-inflammatory":[4],"and":[5,53,66,116],"anti-fibrotic":[6],"effects.":[7],"Several":[8],"pre-clinical":[9],"studies":[10],"have":[11],"shown":[12],"anti-tumoral":[13],"activity":[14],"of":[15,28,58,64,81,103,107,134,138],"silibinin":[16,92,139],"in":[17,141],"breast":[18,32,143],"cancer":[19,33,144],"cell":[20],"lines.":[21],"CASE":[22],"REPORT:":[23],"We":[24],"present":[25],"the":[26,68,97,104,112,121,130],"case":[27,132],"a":[29,59,83,90,135,142],"heavily":[30],"pre-treated":[31],"patient":[34,40,98,113,122],"with":[35,42],"extensive":[36],"liver":[37,44,70,117],"infiltration.":[38],"The":[39,78],"presented":[41,114],"progressive":[43],"failure":[45],"despite":[46],"several":[47],"chemotherapy":[48,61],"treatments,":[49],"including":[50],"paclitaxel,":[51],"capecitabine":[52],"vinorelbine.":[54],"After":[55,109],"four":[56],"cycles":[57],"fourth-line":[60],"treatment":[62,110],"consisting":[63],"carboplatin":[65],"gemcitabine,":[67],"patient's":[69],"blood":[71],"test":[72],"results":[73],"deteriorated":[74],"to":[75,96,100,123],"life-threatening":[76],"levels.":[77],"compassionate":[79],"use":[80],"Legasil\u00ae,":[82],"new":[84,91],"commercially":[85],"available":[86],"nutraceutical":[87],"product":[88],"containing":[89],"formulation,":[93],"was":[94],"offered":[95],"according":[99],"article":[101],"37":[102],"2013":[105],"Declaration":[106],"Helsinki.":[108],"initiation,":[111],"clinical":[115,136],"improvement,":[118],"which":[119],"permitted":[120],"continue":[124],"palliative":[125],"chemotherapy.":[126],"CONCLUSION:":[127],"This":[128],"is":[129],"first":[131],"report":[133],"benefit":[137],"administration":[140],"patient.":[145]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}